Generic Name and Formulations:
Gadoversetamide 330.9mg/mL; soln for IV inj; preservative-free.
Indications for OPTIMARK:
For use with magnetic resonance imaging (MRI) in patients with abnormal blood brain barrier or abnormal vascularity of the brain, spine and associated tissues. For use with MRI to provide contrast enhancement and facilitate visualization of lesions with abnormal vascularity in the liver in patients who are highly suspect for liver structural abnormalities on computed tomography.
Give as bolus peripheral IV injection at a dose of 0.2mL/kg at a rate of 1–2mL/sec.
Chronic, severe renal disease (GFR <30mL/min/1.73m2) or acute renal injury.
Nephrogenic systemic fibrosis (NSF).
Increase risk for nephrogenic systemic fibrosis in patients with impaired elimination of gadolinium-based contrast agents. Screen for acute kidney injury and other conditions that reduce renal function. Use lowest possible dose. Do not exceed recommended dose; allow sufficient period of time for elimination prior to re-administration. Sickle cell anemia and other hemoglobinopathies. Hemolytic anemias. History of asthma, allergy or other respiratory disorders. Anaphylactoid reactions possible; have emergency resuscitative equipment available. Monitor for hypersensitivity during and for several hours after injection; discontinue if occurs. Pregnancy (Cat.C). Nursing mothers: not recommended; discard breast milk up to 72hrs after injection.
Gadolinium-based contrast agent.
Interference in serum iron, copper, zinc, and calcium measurements.
Headache, vasodilation, taste perversion, dizziness, nausea, paresthesia; anaphylaxis (may be fatal).
Vials (5mL, 10mL, 15mL, 20mL)—10; Syringes (10mL, 15mL, 20mL, 30mL)—10
Sign Up for Free e-newsletters
- Choice of Breast Reconstruction After Mastectomy Affects Satisfaction, Quality of Life
- Bariatric Surgery Reduced Risk of Some Cancers in Obese Patients
- Carfilzomib Benefits May Outweigh Cardiovascular Risk in Multiple Myeloma
- The Caregivers' Cancer Journey
- Genetic Link Between Depression and Breast Cancer Remains Unclear
- Implementing an Ambulatory Adherence Program May Improve Oral Anticancer Medications Compliance
- Exercise Habits Influence Mortality in Adult Survivors of Childhood Cancer
- Managing Dyspnea With Fentanyl in Patients With Cancer at End of Life
- CALM: A Depression Intervention for Cancer Patients at the End of Life
- High BMI Among Premenopausal Women May Improve Risk for Breast Cancer
- Fertility Preservation in Hodgkin's Lymphoma Patients That Undergo Targeted Molecular Therapies: An Important Step Forward From the Chemotherapy Era
- Survey of ACEP Councilors Reveals NP, PA Staffing Models, Practice Patterns Vary
- Breath Analysis May Be an Effective Diagnostic for Pancreatic Cancer
- Genetic Susceptibility to Pancreatic Cancer Linked to 6 Specific Gene Mutations
- Dinner Hour and Sleep Habits Affect Risk of Breast, Prostate Cancers
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|